Professor Brendan Crabb AC is Director and CEO of the Burnet Institute in Melbourne. Professor Crabb’s expertise is in the study of infectious diseases, particularly those affecting the developing world. The primary driver for his own laboratory’s research is the development of a malaria vaccine and the identification of new targets for therapeutic intervention.
In addition, Professor Crabb is the Immediate-Past President of the Association of Australian Medical Research Institutes (AAMRI), the peak body representing 8,000 staff and students of Australia’s 40 independent medical research organisations.
He is also Chairman of Alfred Medical Research and Education Precinct (AMREP) Council, Chairman of the PATH/Malaria Vaccine Initiative Science Portfolio Advisory Committee in the US and Chair of the upcoming Gordon Conference on Malaria in Italy, 2013.
Professor Crabb holds Professorial appointments at The University of Melbourne and Monash Universities. Until his appointment as Director of the Burnet Institute he was a Senior Principal Research Fellow of the National Health & Medical Research Council of Australia, and an International Research Fellow of the US-based Howard Hughes Medical Institute.
He serves on the Scientific Advisory Boards of the Sanger Institute’s Malaria Program and the Monash Institute of Pharmaceutical Science. Professor Crabb was the Editor-in-Chief of the world’s leading parasitology research journal the International Journal for Parasitology from 2006 to 2009 and remains on its editorial board along with that of Nature Communications and F1000 Reports.
With a strong interest in education, the former lecturer in the Department of Microbiology and Immunology at The University of Melbourne is currently involved in educational and curriculum development activities for high school students and teachers through the Gene Technology Access Centre.
Companion of the Order of Australia (AC)